Table 4 Effect of crude and flavonoids extracts of Rubus ulmifolius on yeast-induced pyrexia in Rats
From: Pharmacological profile of the aerial parts of Rubus ulmifolius Schott
Groups | Rectal Temperature in °C | ||||||
|---|---|---|---|---|---|---|---|
Normal | Brewer’s yeast | After administration of test samples and standard drug | |||||
1sthr | 2ndhr | 3rdhr | 4thhr | ||||
GI (Control) | 37.36 ± 0.08 | 39.61 ± 0.03 | 39.41 ± 0.04 (8.88%) | 39.48 ± 0.06 (5.92%) | 39.43 ± 0.07 (8.14%) | 39.46 ± 0.04 (6.66%) | |
GII (Paracetamol) | 37.46 ± 0.04 | 39.4 ± 0.06 | 38.86 ± 0.08 (27.58%) | 38.38 ± 0.07 (52.58%) | 38 ± 0.05*** (72.41%) | 37.7 ± 0.05*** (87.93%) | |
Ru.Cr | GIII 150 mg | 37.13 ± 0.03 | 39.45 ± 0.24 | 39.36 ± 0.08 (3.87%) | 39.10 ± 0.15 (15.08%) | 38.76 ± 0.23 (29.74%) | 38.20 ± 0.11* (53.87%) |
GIV 300 mg | 37.23 ± 0.08 | 38.90 ± 0.30 | 38.71 ± 0.08 (11.37%) | 38.36 ± 0.34 (32.33%) | 37.93 ± 0.42** (58.08%) | 37.66 ± 0.38*** (74.25%) | |
Ru.F | GV 150 mg | 37.16 ± 0.08 | 39.36 ± 0.38 | 38.84 ± 0.12 (23.63%) | 38.71 ± 0.35 (29.54%) | 38.53 ± 0.12 (37.72%) | 37.87 ± 0.50** (67.72%) |
GVI 300 mg | 37.26 ± 0.12 | 39.66 ± 0.20 | 38.70 ± 0.45 (40%) | 38.23 ± 0.08** (59.58%) | 37.86 ± 0.18*** (75%) | 37.60 ± 0.05*** (85.83%) | |